Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Panobinostat

EU orphan designation number: EU/3/09/721
Active ingredient: Panobinostat
Indication: Treatment of Hodgkin's lymphoma
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/02/2010 Centralised Orphan - Designation EMEA/OD/096/09 (2010)785 of 02/02/2010
25/04/2012 Other procedure